KERRIN SORRIE: Open Payments
NPI 1982064507 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,077 in 128 payments from 41 companies in 2025. Trend: 2023 $2,555 · 2024 $3,376 · 2025 $3,077
Food & beverage: $2,978Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $388 |
| AstraZeneca Pharmaceuticals LP | 10 | $279 |
| ABBVIE INC. | 9 | $192 |
| Merck Sharp & Dohme LLC | 8 | $189 |
| Daiichi Sankyo Inc. | 9 | $186 |
| Lilly USA, LLC | 4 | $107 |
| SOBI, INC | 4 | $100 |
| Tempus AI, Inc | 1 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| PFIZER INC. | 5 | $90 |
Products named: Enhertu, RYBREVANT, KEYTRUDA, ERLEADA, EPKINLY, OPDIVO, VERZENIO, XT CDX.
Industry payments across TX — which companies pay providers there.
